Potential pharmaceutical drugs in the field of cancer
Raquel Villar Becares, in her PhD thesis at the Public University of Navarre, has developed new derivatives of benzo[b]tiophene 1,1-dioxide that enable their application in the pharmaceutical field. Moreover, the researcher tested for the antitumoural activity of these derivatives, concluding that 23 of the 24 compounds analysed proved to be active or very active against one or more of the tumoural cell lines tested.
Treatment of diabetes or high blood pressure
Although benzo[b]tiophene 1,1-dioxide, found in both crude and processed petroleum oil, was first described in 1893, it was not until the 1950s when it was discovered that the benzo[b]tiophene ring and its derivatives had interesting biological activities for possible use as pesticides, plant growth regulators, analgesics and local anaesthetics and antihistamines, amongst others applications.
In the field of medicine, a bright future is predicted for the possible application of these benzotiophene derivatives as antineoplasic agents. In order to enhance their properties as potential pharmaceutical drugs and to make progress in establishing their mode of action, thus, it was necessary to extend the number of known benzo[b]tiophene derivatives. All this with the end aim of exploring possibilities for their application in the pharmaceutical field as anti-cancer drugs.
The PhD proposed a rational design based on various theoretical methods, thrown up by the new derivatives, the activity of which was subsequently tested. In a parallel manner and, as knowledge was gained about their possible mechanism, Raquel Villar proposed the investigation of possible targets using theoretical docking methods on the protein active structure sites. Subsequently, they were evaluated as cytotoxic agents, tNOX inhibitors and carbonic anhydrase inhibitors.
The activity of these new derivatives was tested, concluding that 23 of the 24 compounds analysed proved to be active or very active against one or more tumoural cell lines tested. Thus, the in vitro cytotoxic activity of 24 new derivatives of benzo[b]tiophene 1,1-dioxide were determined for activity against, amongst others: human lung and leukemia fibroblasts.
More specifically, a number of compounds had an in vitro cytotoxicity comparable to the commercial antineoplasic, Doxorrubicina, used as a positive control of activity in the trials carried out for tumoural growth inhibition.
Garazi Andonegi | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...